Literature DB >> 33983709

A Tail Fiber Engineering Platform for Improved Bacterial Transduction-Based Diagnostic Reagents.

Colin N Lam1, Misha G Mehta-Kolte2, Natacha Martins-Sorenson1, Barbara Eckert2, Patrick H Lin1, Kristina Chu2, Arrash Moghaddasi1, Dylan Goldman1, Hai Nguyen1, Ryan Chan1, Laxmi Nukala1, Shawn Suko2, Brett Hanson1, Richard Yuan1, Kyle C Cady1.   

Abstract

Bacterial transduction particles were critical to early advances in molecular biology and are currently experiencing a resurgence in interest within the diagnostic and therapeutic fields. The difficulty of developing a robust and specific transduction reagent capable of delivering a genetic payload to the diversity of strains constituting a given bacterial species or genus is a major impediment to their expanded utility as commercial products. While recent advances in engineering the reactivity of these reagents have made them more attractive for product development, considerable improvements are still needed. Here, we demonstrate a synthetic biology platform derived from bacteriophage P1 as a chassis to target transduction reagents against four clinically prevalent species within the Enterobacterales order. Bacteriophage P1 requires only a single receptor binding protein to enable attachment and injection into a target bacterium. By engineering and screening particles displaying a diverse array of chimeric receptor binding proteins, we generated a potential transduction reagent for a future rapid phenotypic carbapenem-resistant Enterobacterales diagnostic assay.

Entities:  

Keywords:  Smarticles; antimicrobial resistance; antimicrobial susceptibility testing; bacteriophage; carbapenem-resistant Enterobacterales; synthetic biology

Mesh:

Substances:

Year:  2021        PMID: 33983709     DOI: 10.1021/acssynbio.1c00036

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  1 in total

1.  Construction and Characterization of T7 Bacteriophages Harboring Apidaecin-Derived Sequences.

Authors:  Tobias Ludwig; Ralf Hoffmann; Andor Krizsan
Journal:  Curr Issues Mol Biol       Date:  2022-06-01       Impact factor: 2.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.